HLA genotyping or chip-based microarray technology. By the capture sequencing of 48 entire MHC region for discovery and HLA-typing for validation in 2,773 subjects of 49
Han ancestry, we identified HLA-DQ1:160D as the strongest independent genetic 50 risk for anti-citrullinated protein antibodies (ACPA)-positive RA in Han population 51 (P = 6.16 x 10 −36 , OR=2.29). Further stepwise conditional analysis revealed that 52 DR1:37N has an independent protective effect on ACPA-positive RA (P = 5.81 x 53 10 −16 , OR=0.49). The DQ1:160 coding allele DQA1*0303 displayed high impact on 54 joint radiographic severity, especially in patients with early disease and smoking (P = 55 3.02 x 10 −5 ). Interaction analysis by comparative molecular modeling revealed that 56 the negative charge of DQ1:160D stabilizes the dimer of dimers, leading to an 57 increased T cell activation. The electrostatic potential surface analysis indicated that 58 the negative charged DRβ1:37N encoding alleles could bind with epitope P9 arginine, 59 thus may result in a decreased RA susceptibility. 60
In this study, we provide the first evidence that HLA-DQA1, instead of HLA-DRB1, is 61 the strongest and independent genetic risk for ACPA-positive RA in Chinese Han 62 4 population. Our study also illustrates the value of MHC deep sequencing for fine 63 mapping disease risk variants in the MHC region. 64
INTRODUCTION 65
Rheumatoid Arthritis (RA) is a chronic and systemic autoimmune syndrome primarily 66 affecting peripheral joints. Results from several studies indicate that RA is a 67 heterogeneous disease where different subsets of the disease results from complex 68 interactions between different genetic and environmental factors [1] [2] [3] . The genetic 69 factors are believed to influence not only disease susceptibility but also severity. The 70 major histocompatibility complex (MHC) genes, encoding the human leukocyte 71 antigens (HLA), represent the best described genetic risk loci linking to RA 72 susceptibility in all populations that have been investigated so far. HLA-DR genetic 73 variants are mainly associated with anti-citrullinated protein antibodies 74 (ACPA)-positive RA 4-10 . Furthermore, studies have reported that the RA-risk HLA 75 alleles are heterogeneous among ethnic groups. For example, HLA-DRB1*04:01 is the 76 major RA-risk alleles in European Caucasians, whereas DRB1*04:05 is the most 77 frequent RA-risk alleles in East Asians 8, [11] [12] [13] [14] . In addition to HLA-DRB1, other HLA 78 genes, such as HLA-B and -DPB1, have also been suggested to play a role in 79 susceptibility to RA 9,15 . However, due to the high linkage disequilibrium (LD) in 80 MHC region, extended haplotype structures, and high density genes within MHC 81 region, it is difficult to identify the 'real' or/and additional independent genetic risks 82 by the conventional HLA genotyping and chip-based microarray technology, which 83 defines MHC-resident association(s) based on indirect haplotype determination 16, 17 . 84 6 Smoking has been recognized as the most prominent environmental factor for RA 85 development and severity 18, 19 . One important aspect of smoking as RA-risk factor is 86 its involvement in gene-environment interaction. Smoking has greater impact on RA 87 in individuals being carriers of HLA-DRB1 alleles, and the interaction between 88 smoking and HLA-DRB1 alleles mainly confers a higher risk for ACPA-positive 89 RA 6,20-26 . 90
To fine map HLA region and identify novel variants contributing to RA, we 91 performed a deep sequencing for entire MHC region. We analyzed HLA alleles, 92 amino acids, SNPs, and indels across the MHC region to define the association for 93 ACPA-positive RA. To the best of our knowledge, we showed for the first time that 94 DQ1:160D, instead of DRB1*0405, is the greatest and independent risk factor for 95 ACPA-positive RA in Han population. Conditional analysis further revealed that 96 DR1:37N is an independent protective factor for ACPA-positive RA. We validated 97 and confirmed these novel findings in an independent case-control cohort by classical 98 HLA genotyping methodology. Moreover, we observed that one of DQ1:160D 99 encoding alleles DQA1*0303 confers strong risk for joint destruction in patients with 100 early disease and smoking. 101 102 103 7
MATERIAL AND METHODS 104

Study subjects 105
Two independent cohorts, including 1358 subjects for discovery cohort (357 cases 106 and 1001 controls) and 1415 subjects for validation cohort (604 cases and 811 107 controls), were enrolled in the study. Patients satisfied the American College of 108 Rheumatology 1987 revised criteria for a diagnosis of RA 27 , and were recruited from 109 the Department of Rheumatology and Immunology at Peking University People's 110
Hospital. All cases were ACPA-positive RA patients. ACPA were quantified using a 111 second generation anti-CCP (anti-cyclic citrullinated peptides) antibodies ELISA kit, 112 with a cut-off of 5 RU/mL (Euroimmun, Luebeck, Germany). Among cases, a total of 113 558 x-ray sets of hands were available. All x-rays were chronologically scored for 114 assessment of bone destruction, as described previously 28, 29 . 115
In the discovery cohort, the healthy controls were selected by adjusting with age and 116 sex from the control cohort of a study in psoriasis 30 . In the validation cohort, the 117 healthy subjects were recruited from Health Care Center of People's Hospital and 118
were selected by adjusting with age and sex and without any disease records. All 119 patients and healthy individuals were Han Chinese. The baseline demographic 120 characteristics of patients and healthy controls are summarized in Table 1 and the 121 workflow of this study is described in Supplementary Fig. 1 . 122
The study was approved by the Medical Ethics Committee of Peking University 123
People's Hospital and informed consent was obtained from all participants. 124 8
MHC target sequencing 125
In discovery stage, the MHC region was sequenced using the targeted capture 126 sequencing methodology, as described previously 31 
Alignment and variant calling 140
Sequenced samples were aligned to the NCBI human genome reference assembly 141 (Build 37) using Burrows-Wheeler Aligner (BWA, version 0.5.9). On average, the 142 MHC region was sequenced to a mean depth of 94 X, with 96.6% covered by at least 143 one read and 93.1% covered by at least ten reads for cases. The data summary of the 144 health controls is described in the previous study 30 . Then using SAMtools (v0.1.17), 145 9 the file was conversed from SAM to BAM, the sorted and indexed BAM files were 146 generated and duplicates were marked. To perform the realignment around known 147 Indels, the BAM files were analyzed using the Genome Analysis Toolkit (GATK 148 v1.4). All aligned read data were subjected to CountCovariates (GATK) on the basis 149 of known single-nucleotide variants (SNVs) (dbSNP135) and TableRecalibration (in 150 GATK) was used to recalibrate the base quality. Single nucleotide variants and indels 151 were called jointly with GATK UnifiedGenotyper. Then, the GATK resource bundle 152 was used for variant quality score recalibration, which includes known SNP sites from 153 HapMap v3.3, dbSNP135, the Illumina Omni2.5 array, the Mills and the 1000G gold 154 standard Indels as training data 32 . To build a genotype matrix as input for the 155 subsequent analysis, the genotypes for each detected variant position were extracted 156 from all samples. 157
HLA typing 158
In discovery cohort, a total of 26 highly polymorphic HLA genes were genotyped 159 according to the Short Oligonucleotide Analysis Package (SOAP)-HLA 31 . 160 SOAP-HLA is a flow of sequencing data analysis pipeline to type any HLA genes 161 using capture sequenced data based on IMGT/HLA database with a high accuracy 31 . 162
The following HLA genes were typed including HLA-A, HLA-B, HLA-C, HLA-E, -DRB1 and -DPB1 alleles were determined by using the next generation sequencing 171 (NGS) method 33 . In brief, the amplicons were pooled and sheared randomly. Gel 172 slicing was used to recover the sequencing libraries with fragments which include the 173 library adapters between 400 and 700 bp in length. Then, the sequencing was 174 performed on Illumina Miseq with PE 150 bp reads in a single run. Finally, using the 175 unique variant calling and haploid sequencing assembly algorithm with the short 176 sequence read as input, the genotypes were accurately obtained. HLA-DQA1 were 177 genotyped by sequencing of both exons 2 and 3 using the gold standard Sanger 178 sequencing method 34, 35 . 179
Quality control 180
Sequencing data were evaluated against a quality control metrics for all the samples. 181
We restricted each individual as follows: (i) average sequencing depth 4X; (ii) 90% 182 of the target region covered by 4X; (iii) GC content within 42%-48%. According to 183 the criteria, a total of 58 samples from the discovery stage were filtered and removed 184 for further analysis ( Supplementary Table 1 ). 185
After initial sample quality control for the MHC capture sequencing, we performed 186 further filtering to identify the high-confidence SNPs and Indels in targeted region. 187 11 Following criteria were applied: i) pass ratio  0.9 (Q100 and Q500 were defined as 188 pass for SNPs and Indels, respectively); ii) missing rate  0.1 (a depth of  5X was 189 considered as high quality; individuals failed to meet the criteria were considered as 190 missing); iii) minor allele frequency (MAF)  0.01; iv) Hardy-Weinberg test P-value 191  1.0 x 10 -6 (Supplementary Table 2 ). For HLA types and amino acids, the same 192 process was performed except for the pass ratio criteria ( Supplementary Table 2 ). 193
Statistical analyses 194
Using the same data processing procedure and analysis 30,36 , logistic regression model 195 was applied to test the association between ACPA-positive RA and the variants in the 196 MHC region, adjusting by gender. We define the HLA variants by including the four 197 digit biallelic classical HLA alleles, biallelic SNPs, Indels, and biallelic HLA amino 198 acid polymorphisms for respective residues within MHC region. The top five 199 principal-components (PCs) were applied to control for population stratification in the 200 discovery study. For the individual HLA allele and amino acid variant, the association 201 was determined after stratifying the data using the relative predispositional effect 202 (RPE) method 37 . Thus, the logistic regression model is as follows: 203
Where Y1 is RA status (1 if ACPA-positive RA and 0 otherwise) and xk is the 205 genotype at the kth variants. The 0 is the logistic regression intercept and 1, 2, 3
206
are the effect size of kth variants, gender and the PCA respectively. The P values for 207 this test were observed while the odds ratio (OR) and standard error (SE) of OR were 208
estimated. 209
To assess the independent effects of candidates identified in logistic analysis, we 210
assumed the logistic regression model additionally including the most significant loci 211 as covariates for the stepwise conditional regression analysis. If additional 212 independent risk factors were identified, we further consecutively included them as 213 covariates in the subsequent multivariate analyses in a forward conditional stepwise 214 manner until none of loci met the cut off P-value 30, 38 . Assuming that there may be 215 linkage disequilibrium (LD) between the intergenic regulatory variants and specific 216 genes, thus the independence of intergenic variants from its surrounding genes should 217 be tested 36 . If the P-value of the intergenic variants is no longer less than the 218 significant threshold after conditioning on the polymorphism sites (including SNPs, 219
INDELs, amino acids, HLA type) of the nearby genes, we should perform condition 220 analysis on its tagged genes, otherwise the intergenic variant is considered a real 221 independent association locus. The unpaired T-test was applied to assess the 222 significance of differences in radiological scores between two groups. 223
In discovery stage, a P-value less than 1.0 x 10 -5 was suggested as significance 224 threshold. In validation and combined stages, a conventional genome-wide statistical 225 significance threshold of P less than 5.0 x 10 -8 was applied. Analysis of radiological 226 severity was conducted in R statistics program. 227
Comparative modeling 228 13
The comparative modeling was conducted using Modeller v9.14 39 . The crystal 229 structure of HLA-DR1 (DRA-DRB1*0101) (PDB ID: 1AQD) was employed as 230 template for comparative modeling of DQA1*0303-DQB1*0401 40 . The overall 231 sequence identify and similarity between DQA1*0303-DQB1*0401 and HLA-DR1 232 are 61.7% and 76.6%, respectively. The crystal structure of HLA-DR3 233 (DRA-DRB1*03:01) (PDB ID: 1A6A) has been solved and thereby was used as 234 template for the comparative modeling of DRA-DRB1*13:01 and DRA-DRB1*13:02 41 . 235
The sequence identities of HLA-DR3 to DRA-DRB1*13:01 and DRA1-DRB*13:02 236 were 98.1%, and 97.8%, respectively. For each comparative modeling, ten models 237 were generated, and the structure with the lowest probability density function total 238 energy was selected for structural refinement. Energy minimization was performed 239 using the Amber14 package with the Amber ff14SB force field 42 . Each structure 240 model was solvated in an octahedron TIP3P water box and neutralized by adding 241
proper counter ions. The distance of box boundary and structure model was set to 10 242 Å. The particle-mesh-Ewald (PME) method 43 was used for the treatment of 243 long-range electrostatic interactions. The non-bond interaction cutoff was set to 8.0 Å. 244
Each simulation system was subjected to three stages of energy minimization, 245 Table 2) . 263
In total, 563 variants (including HLA types and amino acids) showed significant 264 associations by a cut-off of P-value less than 1.0 x 10 -5 ( Supplementary Table 3 ). 265
We found that the top association signal was mapped to HLA-DQA1, with a peak at 266 HLA-DQ1 amino acid position 160 (DQ1:160D, P = 4.03 x 10 −14 , OR=2.42, 95% 267 CI 1.92-3.04), followed by DQ1:160A (P = 2.01 x 10 −13 , OR=2.34, 95% CI 268 1.86-2.93) and DQA1*0303 (P = 2.62 x 10 −13 , OR=3.02, 95% CI 2.25-4.06) ( Fig. 1  269 and Supplementary Table 3 ). HLA-DRB1*0405 allele, the putative greatest RA risk 270
in Asians in previous reports, also showed a strong association with ACPA-positive 271
RA, but fell out of the top 10 risk variants (P = 9.48 x 10 −12 , OR=3.22, 95% CI 272 2.30-4.50) ( Supplementary Table 3 ). By stepwise conditional analysis on HLA-DQ1:160D, the second signal was 277 mapped to a list of SNPs, with a peak at rs7764856 (chr6_32680640_T_A) 278
( Supplementary Table 4 ). The SNPs are in high LD (r 2 = 0.72) and all located in 279 intergenic region between DQA2 and DQB1 according to NCBI RefSeq database 280 (http://www.ncbi.nlm.nih.gov/RefSeq). An immediate significant association was 281 observed for HLA-DR1:37N after these intergenic SNPs ( Fig. 1 and 282 Supplementary Table 4 ). Of note, HLA-DR1:37N has an independent protective 283 effect on ACPA-positive RA (P = 2.71 x 10 −6 , OR=0.51, 95% CI 0.39-0.68). 284
Conditioning on DR1:37N, the intergenic SNPs lost their association and no 285 additional independent association(s) reached the suggestive statistical significance 286 threshold of P < 1.0 x10 -5 (data not shown). 287
To assess whether DQ1:160D and DR1:37N were independent of each other, we 288 performed the conditional analysis starting from DR1:37N. As shown in 289 Supplementary Fig. 2 , after conditioning on DR1:37N, DQ1:160D displayed even 290 stronger association (P = 1.19 x 10 −18 , OR=3.53, 95% CI 2.67-4.68). This indicates 291 that DQ1:160D also has an independent effect on ACPA-positive RA. 292
The validation study confirms the findings discovered by capture sequencing 293
To validate the findings discovered by capture sequencing, we performed Sanger or 294 NGS to genotype HLA-A, -B, -DRB1, -DQA1, and -DPB1 genes in an independent 295 case-control cohort, consisting of 604 cases with ACPA-positive RA and 811 healthy 296 17 subjects. Joint analysis was then performed by combining the results from discovery 297 and validation cohorts. 298
In line with the findings in the discovery stage, DQ1:160D showed consistent top 299 association with ACPA-positive RA in the validation panel (P = 7.14 x 10 −19 , OR = 300 2.23, 95% CI 1.87-2.66), followed by DQA1*0303 (P = 5.74 x 10 −18 , OR = 3.13, 95% 301 CI 2.41-4.05) and DQ1:160A (P = 4.18 x 10 −17 , OR=2.10, 95% CI 1.77-2.50). A 302 consistent association was also observed for DRB1*0405 (P = 5.76 x 10 −15 , OR = 3.40, 303 95% CI 2.50-4.62) ( Supplementary Table 5 ). After conditioning to DQ1:160D, 304 though DR1:96H became the second independent signal (P = 2.80 x 10 −10 , OR = 305 1.68, 95% CI 1.43-1.97), it was followed by DR1:37N (P = 1.93 x 10 −8 , OR=0.51, 306 95% CI 0.40-0.65) ( Supplementary Table 6 ). When conditioning on DR1:37N, the 307 DR1:96H lost the association according to the genome-wide statistical significance 308 threshold of P < 5.0 x 10 -8 (P = 1.18 x 10 −4 , OR = 1.45, 95% CI 1.20-1.76, data not 309 shown). 310 Joint analysis of discovery and replication panels provided compelling evidence that 311 HLA-DQ1:160D conferred the highest risk on ACPA-positive RA (P = 6.16 x 10 −36 , 312 OR=2.29, 95% CI 2.01-2.60), followed by DQ1:160A (P = 3.29 x 10 −33 , OR=2.17, 313 95% CI 1.91-2.47) and DQA1*03:03 (P = 5.13 x 10 −33 , OR=3.17, 95% CI 2.63-3.83) 314 ( Fig. 2, Supplementary Table 7 , and Table 2 ). After conditioning to DQ1:160D, 315 though the DR1:96H remained as the second independent signal (P = 4.90 x 10 −16 , 316 OR=1.64, 95% CI 1.45-1.84, Fig. 2 and Supplementary Table 7) , DR1:37N also 317 18 displayed strong association (P = 5.81 x 10 −16 , OR=0.49, 95% CI 0.41-0.58, Fig. 2 , 318 Supplementary Table 7, and Table 2 ). When conditioning on DR1:37N, there was 319 no additional independent association(s) reached the study-wide statistical 320 significance of P < 5.0 x 10 -8 (data not shown). 321
Exclusive dissection of HLA-DRB1 indicates that DR1 variants could be strong 322 risks for ACPA-positive RA, if the effect of HLA-DQA1 is ignored. 323
As mentioned above, HLA-DRB1 was recognized as the strongest RA risk in previous 324 studies, especially for ACPA-positive RA and variations DRB1*0405, DR1:11, 13, 325 57, 74, and 71 have been shown to confer risks for RA in Asian patients 10 . Thus, we 326 next investigated RA association at HLA-DRB1 separately. As shown in 327 Supplementary Table 8 , multiple alleles at HLA-DRB1 showed strong associations, 328 with DR1:120N (P = 6.46 x 10 −28 , OR=2.27, 95% CI 1.96-2.63), DRB1*0405(P = 329 6.55 x 10 −28 , OR=3.40, 95% CI 2.73-4.23), and DR1:11V (P = 2.43 x 10 −27 , 330 OR=2.45, 95% CI 1.94-2.60) being the top three risks. When conditioning on either 331 DR1:11V or :120N, the second signal was seen for DR1:31I (P = 2.23 x 10 -18 , 332 OR=1.93, 95% CI 1.67-2.24) and DR1:13F (P = 2.90 x 10 −17 , OR=1.82, 95% CI 333 1.58-2.09) (Fig. 3) . After further conditioning to either DR1:13F or :31I, strong 334 association signals were observed for DRB1*04:05 (P = 6.26 x 10 −11 , OR=2.53, 95% 335 CI 1.92-3.35) and DR1:57S (P = 3.14 x 10 −9 , OR=1.81, 95% CI 1.49-2.20), 336
respectively. Then we continued conditioning on DR1:57S, DR1:74A showed a 337 suggestive association with ACPA-positive RA (P = 5.09 x 10 -7 , OR = 0.72, 95% CI 338 19 0.63-0.82). When conditioning on DR1:74A, DR1:71E also showed a suggestive 339 association (P = 2.95 x 10 −6 , OR=0.37, 95% CI 0.24-0.56). Our results indicated that 340 if the effect of DQA1 is ignored, DRB1*0405, amino acid variants at DR1:11, 13, 57, 341 74, and 71 can come up and be very strong risk factors for ACPA-positive RA. 342
Next, we compared the individual amino acid frequencies between Han Chinese and 343
European populations. As shown in Fig. 4A , both DQ1:160D and DQ1:160A are 344 common amino acids in Han Chinese and were significantly increased in 345 ACPA-positive RA patients. However, the two amino acids have not been detected in 346
European population 9 . For amino acid positions 11, 13, 57, 71 and 74 in DR1, the 347 amino acid frequencies are similar between two ethnic groups or case and controls, 348 except for a few amino acids. For example, DR1:11D, 13G, 57V, and 74E are 349 common in Han Chinese but rare in Europeans (Fig. 4B, C, D, F) . In contrast, 350 DR1:71K is rare in Han Chinese but common in Europeans (Fig. 4E) . patients with available SHS data were divided into three groups according to the 357 disease durations ( 1 years, 1-10 years, or  10 years). Overall, there was no 358 difference in SHS according to either DQ1:160 variations or its coding allele 359 20 polymorphisms in three disease stages (data not shown). As smoking is a 360 well-established environmental factor contributing to ACPA-positive RA 361 susceptibility and severity, we further stratified the patients by smoking status. 362
Though there was no significant difference in SHS between DQ1:160D carriers and 363 non-carriers after stratifying by smoking status, in the early disease stage one of its 364 coding allele DQA1*0303 showed high impact on radiographic scores in smoking 365 group (P = 3.02 x 10 −5 ). Similarly, in early disease stage DQA1*0303 carriers with 366 smoking had higher radiographic scores than DQA1*0303 carriers without smoking 367 (P = 4.05 x 10 −8 , Fig. 5a ). In the early disease stage DRB1*0405 also showed a higher 368 impact on radiographic score in smoking group (P = 3.02 x 10 −5 ). DRB1*0405 369 carriers with smoking had increased radiographic scores, compared to DRB1*0405 370 carriers without smoking (P = 6.96 x 10 −6 , Fig. 5b) . These findings are consistent 371 with previous finding that the gene-environment interaction between DRB1 variants 372 and smoking contribute to ACPA-positive RA. Our data also suggest that DQ1:160 373 coding allele DQA1*0303 has high impact on radiographic severity of ACPA-positive 374 RA, especially in patients with early disease and smoking. dimer, which may lead to an increased T cell activation (Fig. 6B) . 394
The negatively charged P9 pockets from DRβ1: 37N encoding alleles benefit 395 electrostatic interaction and epitope P9 arginine binding 396
It is well accepted that HLA-DRB1 susceptibility alleles are strongly associated with 397 ACPA-positive RA, and its encoded molecules preferentially present the citrullinated 398 autoantigens 48 . The susceptibility is determined by the electrostatic property of 399 antigen binding pockets and the ability to differentially recognize citrullinated 400 antigens. The positively charged antigen binding pocket in RA-susceptible alleles 401 22 preferentially accommodate citrullinated antigens, whereas electronegative or 402 electroneutral pockets in RA-resistant alleles can bind both arginine and citrullined 403 antigens 49 . The amino acid residues at position 37 in DRβ1 are located within the P9 404 pocket of antigen binding groove. By sequence analysis, we found four alleles 405 containing an asparagine at position DRβ1:37 (Asn37β or 37N), including 406 DRB1*03:01, *09:01, *13:01, and *13:02. Though DRB1*0901 was reported to be 407 the risk allele for RA in Koreans 11 , its influence on developing of ACPA-positive RA 408 subgroup seemed protective 50,51 . We then constructed the structure models for other 409 allele-containing haplotypes by comparative modeling. The electrostatic potential 410 surface and the residues of the P9 pocket from the three models are shown in Fig. 7,  411 respectively. DRA1-DRB1*03:01, DRA1-DRB1*13:01 and DRA1-DRB1*13:02 share 412 identical P9 pocket, which is composed of Asn69α, Met73α, Tyr30β, Asn37β, Val38β 413 and Asp57β (Fig. 7D, E and F) . The electrostatic potential surface analysis indicates 414 that P9 pockets of DRA1-DRB1*03:01, DRA1-DRB1*13:01 and DRA1-DRB1*13:02 415 are negatively charged and could benefit electrostatic interaction with epitope P9 416 arginine (Fig. 7A, B and C) . Collectively, all three alleles containing negatively 417 charged P9 pocket of Asn37 could bind the epitope P9 arginine and thus may result in 418 a decreased RA susceptibility. Previously, a number of reports have shown that the greatest genetic risk for 430 ACPA-positive RA came from certain HLA-DRB1 alleles 52-54 , in which the 431 DRB1*0405, DR1:11, 13, 57, 74, and 71 were reported as strong risks for Asian RA 432 patients 10 . However, even though the classical HLA-DRB1 alleles have been reported 433 to confer strong RA risks in different populations, other HLA genes have also been 434 shown to associate with ACPA-positive RA. For example, Raychaudhuri et al. have 435 reported that single-amino-acid variations in HLA-B (at position 9) and HLA-DP1 436 (at position 9) were strong risks for seropositive RA, besides other three amino acid 437 positions (11, 71 and 74) in HLA-DR1 9 . Another study also reported a strong 438 association with ACPA-positive RA at HLA-A amino acid position 77 15 . It has thus 439 been a challenge to draw definitive conclusion concerning the role of different MHC 440 class II alleles in susceptibility to ACPA-positive RA. 441 24 In present study, we identified HLA-DQ1:160D as the strongest and independent 442 genetic risk instead of the well-known HLA-DRB1 alleles for ACPA-positive RA in 443
Han population. Our novel finding could be rationally explained by the fact that 444 DQ1:160D is encoded by two alleles, i.e. DQA1*0302 and *0303. Though the two 445 alleles are common in East Asians, they are rare variants in 446
Caucasians 55,56 (http://www.allelefrequencies.net/hla6006a.asp). Thus, the SNPs 447 tagging DQA1*0302 and *0303 may not be included in DNA beadchips for GWAS. 448
This could help to explain why DQ1:160D and its coding alleles *0302 and *0303 449 have not been detected or suggested to be risk factors for RA, though many RA 450
GWASs and chip-based genotypic imputations have been performed, including a 451 recent large-scale HLA imputation study of ACPA-positive RA in Japanese 452 population 57 . Furthermore, differences between our findings and previously reported 453 HLA associations could also be due to the progress in HLA typing methodology using 454 sequencing technology that covers the whole MHC class II region, which allows 455 typing of HLA alleles at a much higher resolution than before. Notably, however, in 456 our previous work we have showed that HLA-DQA1*03 is significantly associated 457 with RA susceptibility (allelic frequencies: 0.351 vs. 0.256, P = 4.76 x 10 -4 , OR = 458 1.56, 95% CI 1.22-2.03) 8 . Consistently with our finding, Raychaudhuri 9 also reported 459 the allelic frequencies of DQA1*03 to be increased in seropositive RA patients 460 compared to healthy controls (0.462 vs. 0.185). Moreover, DQA1*0302 has been 461 reported as a genetic risk for Vitiligo and Ocular myasthenia gravis in Chinese Han 462 25 population 58,59 , and for Type 1 diabetes mellitus in children in Japanese population 60 . 463
In agreement with previous studies, our data indicated that HLA-DRB1*0405, 464 DR1:11, 13, 57, 74, and 71 could be strong risks for ACPA-positive RA, if the 465 DQA1 association was not noted. 466
It has been well established that smoking is a risk factor linked to RA susceptibility 467 and severity and this risk is increased by a gene-environment interaction between 468 smoking and DRB1 alleles and restricted to ACPA-positive RA. Consistent with 469 previous finding 14 , we now also show that DRB1*0405 carriers with smoking had 470 increased radiographic damage in ACPA-positive RA patients at an early stage of 471 disease. We further show that one of DQ1:160 coding allele DQA1*0303 has high 472 impact on radiographic severity of ACPA-positive RA, especially in patients with 473 smoking and in early disease. Our data thus supports the notion that smoking, in the 474 presence of RA-risk genetic background, may trigger immunity to citrullinated 475 proteins and lead to RA development and accelerate joint damage. 476
Although DQ1:160 locate far away from antigen binding groove and may have little 477 influence on epitope binding, it is adjacent to the DQ -DQ dimer of dimer interface. 478
Previous study has reported that the amino acid substitutions in the dimer of dimer 479 interface of HLA-DR1 inhibited CD4 + T cell activation 61 . Therefore, we assume that 480 the residue substitutions at DQα1:160 may contribute to the dimer of dimer structure 481 stability and T cell activation. Indeed, by electrostatic interaction analysis we 482 observed a strong electrostatic interaction between negatively charged DQ1 483 26 interface residues and positively charged DQ1' interface residues. Compared to the 484 non-charged A160α or S160, the additional negative charge introduced by D160α 485 further enhances the interaction with DQ1, leading to an increased T cell activation. 486
The DR1:37 residue is located within pocket P9 on the beta-sheet floor with their 487 side chains oriented into the peptide-binding groove. Modification of DR1:37 488 residue is sufficient to alter the T-cell receptor peptide recognition 62,63 . Pocket P9 of 489 class II molecules has been linked to several autoimmune diseases. For example, 490 amino acid variations within the pocket P9 of HLA-DR have been shown to 491 associate with increased risk for primary Sjogren's syndrome 64 . DR1:37N was a risk 492 residue for susceptibility to primary sclerosing cholangitis 65 . In present work, by 493 electrostatic potential surface analysis we showed that three DRβ1:37N encoding 494 alleles *03:01, *13:01, and *13:02 have negative charged P9 pocket, which benefits 495 electrostatic interaction and could bind with epitope P9 arginine, thus could at least 496 partly explain its protective effect for ACPA-positive RA discovered in present study. 497
In summary, by sequencing of the entire MHC region for discovery and HLA 498 genotyping for validation in two independent cohorts, our study demonstrates that 499 HLA-DQA1, instead of HLA-DRB1, confers the greatest independent genetic risk for 500 ACPA-positive RA in Chinese Han. Our study also illustrates the value of deep 501 sequencing for fine mapping real risk variants in the MHC region. We thank the staff from Department of Rheumatology and Immunology, People's 505
Hospital, Peking University, for recruiting patients and healthy controls, the staff from 506 the Computing Platform of the Center for Life Sciences, Peking University, for 507 assisting the functional prediction analysis, and the staff from BGI-Shenzhen who 508 contributed to the technical assistance. We wish to thank the patients and healthy 509 volunteers for their cooperation and for giving consent to participate in this study. 
